Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody
10.1371/journal.pone.0102415
Saved in:
Main Authors: | Ng O.-W., Keng C.-T., Leung C.S.-W., Peiris J.S.M., Poon L.L.M., Tan Y.-J. |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Article |
Published: |
Public Library of Science
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142457 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
by: Ter Meulen J., et al.
Published: (2018) -
The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
by: Leth-Larsen, R., et al.
Published: (2011) -
Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro
by: Kam, Y.-W., et al.
Published: (2015) -
SARS coronavirus spike protein expression in HL-CZ human promonocytic cells: Monoclonal antibody and cellular transcriptomic analyses
by: Narasaraju, T., et al.
Published: (2016) -
Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E
by: Siritorn Butrapet, et al.
Published: (2018)